… study has shown that the efficacy of chemotherapy with the mFOLFOX6 regimen among
elderly gastric cancer patients … efficacy among younger gastric cancer patients in terms of RR, …

… Comorbid health conditions and older age appear to influence … with older patients more
likely to receive shorter chemotherapy regimens with less toxicity [23–27]. The goal of this study …

… analysis in a series of 94 mCRC patients. Using the cut-off of 70 years, we compared elderly
patients … (RDI), duration], chemotherapy toxicity and efficacy [objective response rate (ORR), …

… of this study suggest that AZA may be considered a valid alternative for older patients with …
and IC should rely on patient’s clinical and biological fitness, patients’ willingness, logistics (eg…

… to carry out a comparative analysis. In total, there were 64 non-elderly patients treated using
… In conclusion, the present retrospective study suggests that elderly patients should have the …

… impact of chemotherapy on QoL in elderly patients is crucial. This study compared QoL in
patients aged < 65 years and 65 to 70 years receiving adjuvant chemotherapy as a secondary …

… In the current study of elderly patients, the median survival after surgery alone was 13
months compared with 16 months for those who received chemotherapy after surgery. …

… -agent chemotherapy among elderly patients aged 70 years or more. It also aimed to assess
the comparative efficacy and side effects of regimens including platinum derivates or not. …

… withholding treatment, elderly patients should receive chemotherapy as often as nonelderly
… was determined by comparing a reported estimate for elderly patients to a reported estimate …

… Our data show the vulnerability of older patients with cancer to the toxic effects of chemotherapy
and thus the importance of a multidisciplinary and tailored approach to each patient. …